Hot Features
| Actionnaire | Type | Détenues (Réel) | % en Circulation | Valeur Marchande | Date de Reporte |
|---|---|---|---|---|---|
| FMR LLC | Institution | 23 122 660 | 13,53% | US$ 758,19M | 2026-03-31 |
| BlackRock, Inc. | Institution | 16 045 014 | 9,39% | US$ 526,12M | 2026-03-31 |
| Commodore Capital Master LP | Institution | 9 602 000 | 5,62% | US$ 314,85M | 2025-09-30 |
| Deerfield Management Company, L.P. | Institution | 9 043 903 | 5,29% | US$ 296,55M | 2026-03-31 |
| Deerfield Partners, LP | Institution | 9 043 903 | 5,29% | US$ 296,55M | 2026-03-31 |
| Vanguard Portfolio Management, LLC | Institution | 7 333 333 | 4,29% | US$ 240,46M | 2026-03-31 |
| Vanguard Capital Management, LLC | Institution | 6 894 959 | 4,03% | US$ 226,09M | 2026-03-31 |
| The Column Group, LLC | Institution | 6 798 162 | 3,98% | US$ 222,91M | 2025-09-30 |
| TCG Crossover Fund I, L.P. | Institution | 6 798 162 | 3,98% | US$ 222,91M | 2025-09-30 |
| Janus Henderson Group plc | Institution | 5 965 125 | 3,49% | US$ 195,60M | 2026-03-31 |
| Point72 Asset Management, L.P. | Institution | 5 926 826 | 3,47% | US$ 194,34M | 2026-03-31 |
| State Street Global Advisors, Inc. | Institution | 5 663 543 | 3,31% | US$ 185,71M | 2026-03-31 |
| Fairmount Funds Management LLC | Institution | 5 542 832 | 3,24% | US$ 181,75M | 2026-03-31 |
| Fairmount Healthcare Fund II L.P. | Institution | 5 542 832 | 3,24% | US$ 181,75M | 2026-03-31 |
| RTW Investments, LP | Institution | 5 458 675 | 3,19% | US$ 178,99M | 2026-03-31 |
| Commodore Capital LP | Institution | 5 240 007 | 3,07% | US$ 171,82M | 2026-03-31 |
| TCG Crossover Management, LLC | Institution | 4 946 894 | 2,89% | US$ 162,21M | 2026-03-31 |
| Paradigm BioCapital International Fund Ltd. | Institution | 4 906 897 | 2,87% | US$ 160,90M | 2025-02-05 |
| Kynam Capital Management, LP | Institution | 4 037 331 | 2,36% | US$ 132,38M | 2026-03-31 |
| The Goldman Sachs Group, Inc. | Institution | 4 032 988 | 2,36% | US$ 132,24M | 2026-03-31 |
| Geode Capital Management, LLC | Institution | 3 699 519 | 2,16% | US$ 121,31M | 2026-03-31 |
| Wellington Management Group LLP | Institution | 3 578 622 | 2,09% | US$ 117,34M | 2026-03-31 |
| T. Rowe Price Group, Inc. | Institution | 3 212 815 | 1,88% | US$ 105,35M | 2026-03-31 |
| Lord, Abbett & Co. LLC | Institution | 3 181 270 | 1,86% | US$ 104,31M | 2026-03-31 |
| Emerald Advisers, LLC | Institution | 2 616 964 | 1,53% | US$ 85,81M | 2026-03-31 |
| Octagon Capital Advisors LP | Institution | 2 350 000 | 1,37% | US$ 77,06M | 2026-03-31 |
| Invesco Ltd. | Institution | 2 259 649 | 1,32% | US$ 74,09M | 2026-03-31 |
| Holocene Advisors, LP | Institution | 2 250 196 | 1,32% | US$ 73,78M | 2026-03-31 |
| Sofinnova Investments, Inc. | Institution | 2 113 551 | 1,24% | US$ 69,30M | 2026-03-31 |
| Venrock Healthcare Capital Partners III, L.P. | Institution | 2 086 130 | 1,22% | US$ 68,40M | 2025-06-30 |
| VR Management, LLC | Institution | 2 003 051 | 1,17% | US$ 65,68M | 2026-03-31 |
| D. E. Shaw & Co., L.P. | Institution | 1 868 389 | 1,09% | US$ 61,26M | 2026-03-31 |
| Pictet Asset Management Limited | Institution | 1 798 768 | 1,05% | US$ 58,98M | 2026-03-31 |
| Citadel Advisors LLC | Institution | 1 714 927 | 1,00% | US$ 56,23M | 2026-03-31 |
| Artal Group S.A. | Institution | 1 709 279 | 1,00% | US$ 56,05M | 2026-03-31 |
| Marshall Wace LLP | Institution | 1 600 168 | 0,94% | US$ 52,47M | 2026-03-31 |
| Candriam, Société En Commandite Par Actions | Institution | 1 516 297 | 0,89% | US$ 49,72M | 2026-03-31 |
| Woodline Partners LP | Institution | 1 509 557 | 0,88% | US$ 49,50M | 2026-03-31 |
| Venrock Healthcare Capital Partners EG, L.P. | Institution | 1 422 666 | 0,83% | US$ 46,65M | 2025-06-30 |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales
Vous avez déjà un compte? Connexion
Vous n'avez pas de compte ? Inscription
En m'inscrivant, je confirme avoir lu, compris et accepté les Conditions générales d'ADVFN et j'affirme etre un investisseur privé.